Wolverine Asset Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Wolverine Asset Management’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-192,054	Closed	-$4.63M	–	2867
2014 Q2	$4.63M	Buy	192,054 +166,054	+639%	+$1.73M	0.1%	161
2014 Q1	$156K	Sell	26,000 -32,300	-55%	-$225K	﹤0.01%	959
2013 Q4	$348K	Buy	58,300 +43,600	+297%	+$202K	0.01%	914
2013 Q3	$76K	Sell	14,700 -2,300	-14%	-$10.1K	﹤0.01%	1575
2013 Q2	$61K	Buy	+17,000	New	+$69.5K	﹤0.01%	1625

Wolverine Asset Management's IDIX Position: Q3 2014 in Review

Wolverine Asset Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 192,054 shares — an estimated $4.63M sold.

Wolverine Asset Management first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $4.63M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Wolverine Asset Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Wolverine Asset Management sold 192,054 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $4.63M.
Wolverine Asset Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Wolverine Asset Management's IDENIX PHARMACEUTICALS INC position peaked at $4.63M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Wolverine Asset Management's 13F filing for Q3 2014, filed 13 Nov 2014.